Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Tilly
The 5-Year Follow-Up Results of the C5r Protocol With Rituximab and Intrathecal Liposomal Cytarabine for Primary CNS Lymphoma: A Prospective Phase 2 Study of the Lysa
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Refinement of Mum1 Expression Threshold for Double Positive Cd10+ Mum1+ Diffuse Large B Cell Lymphoma Allows a Better Cell of Origin Classification for GCB Subtype
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Polarix: A Phase 3 Study of Polatuzumab Vedotin (Pola) Plus R-CHP Versus R-Chop in Patients (Pts) With Untreated DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Interim Report From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Rituximab Plus Lenalidomide Is as Effective as Immunochemotherapy in the Eradication of Molecular Disease in Untreated Follicular Lymphoma: Relevance Lysa Ancillary Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Landscape of Somatic Mutations of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
‹
1
2
